BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e14605-e14605
Author(s):  
Michael Sorich ◽  
Andrew Rowland ◽  
Mafalda Dias ◽  
Ross Allan McKinnon ◽  
Ganessan Kichenadasse ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document